News / Events :: Sonoma Pharmaceuticals, Inc. (SNOA)

Recent News View All News

Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA

August 6, 2026

Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn(R) Wound Irrigation Solution

June 30, 2026

Upcoming Events View IR Calendar

2026 Annual Meeting of Stockholders

Sep 16, 2026 • 2:00pm MDT

View IR Calendar

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings